Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer

Journal of Nuclear Medicine

Volumn 49, Issue 6, 2008, Pages 1017-1023

  Jentzen, Walter ^a   Freudenberg, Lutz ^a   Eising, Ernst G ^a   Sonnenschein, Wilfried ^a   Knust, Jochen ^a   Bockisch, Andreas ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Differentiated thyroid cancer; Dosimetry; Iodine 124; PET; Radionuclide therapy

Indexed keywords

IODINE 124; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOSIMETRY; FEMALE; HUMAN; KINETICS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; THYROID CANCER; TIME; TUMOR DIFFERENTIATION; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; EVALUATION; HEALTH CARE QUALITY; METHODOLOGY; MIDDLE AGED; QUALITY CONTROL; RADIOMETRY; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; THYROID NEOPLASMS;

EID: 44849105514     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.047159     Document Type: Article

References (13)

1. 124I-PET/ CT in staging of patients with differentiated thyroid cancer. Eur Radiol. 2004;14:2092-2098.
2. 124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact. Nuklearmedizin. 2007;46:121-128.
3. Erdi YE, Macapinlac H, Larson SM, et al. Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Pos Imag. 1999;2:41-46.
4. Eschmann SM, Reischl G, Bilger K, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med Mol Imaging. 2002;29:760-767.
5. Sgouros G, Kolbert KS, Sheikh A, et al. Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med. 2004;45:1366-1372.
6. Jentzen W, Weise R, Kupferschläger J, et al. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems. Eur J Nucl Med Mol Imaging. 2007;35:1619-7070.
7. International Eletrotechnical Commission. International Standard IEC 61675-1: Radionuclide Imaging Devices - Characteristics and Test Conditions - Part 1: Positron Emission Tomographs. Geneva, Switzerland: International Eletrotechnical Commission; 1998.
8. Jentzen W, Freudenberg LS, Heinze M, et al. Segmentation of PET volumes by iterative image thresholding. J Nucl Med. 2007;48:108-114.
9. Knoop BO, Geworski L, Hofmann M, et al. Use of recovery coefficients as a test of system linearity of response in positron emission tomography. Phys Med Biol. 2002;47:1237-1254.
10. Maxon HR, Thomas SR, Samaratunga RC. Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer. Thyroid. 1997;7:183-187.
11. Snyder WS, Ford MR, Warner GG, et al. "S," Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs. MIRD Pamphlet 11. Reston, VA: Society of Nuclear Medicine; 1975.
12. Lin L, Hedayat AS, Sinha B, et al. Statistical methods in assessing agreement: models, issues, and tools. J Am Stat Assoc. 2002;97:257-270.
13. Partik BL, Stadler A, Schamp S, et al. 3D versus 2Dultrasound: accuracy of volume measurement in human cadaver kidneys. Invest Radiol. 2002;37:489-495.